[1]秦 燕.五水头孢唑林钠治疗扁桃体周围炎的临床疗效及对PCT、TNF-α及IL-6水平的影响[J].医学信息,2023,36(09):106-108,123.[doi:10.3969/j.issn.1006-1959.2023.09.021]
　QIN Yan.Clinical Efficacy of Cefazolin Sodium Pentahydrate in the Treatment of Peritonsillitis and its Effect on PCT,TNF-α and IL-6 Levels[J].Journal of Medical Information,2023,36(09):106-108,123.[doi:10.3969/j.issn.1006-1959.2023.09.021]
点击复制

五水头孢唑林钠治疗扁桃体周围炎的临床疗效及对PCT、TNF-α及IL-6水平的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年09期
页码:
106-108,123
栏目:
论著
出版日期:
2023-05-01

文章信息/Info

Title:
Clinical Efficacy of Cefazolin Sodium Pentahydrate in the Treatment of Peritonsillitis and its Effect on PCT,TNF-α and IL-6 Levels
文章编号:
1006-1959（2023）09-0106-04
作者:
秦 燕
（南通市通州区中医院耳鼻喉科，江苏 南通 226300）
Author(s):
QIN Yan
(Department of Otolaryngological,Nantong Tongzhou District Hospital of Traditional Chinese Medicine,Nantong 226300,Jiangsu,China)
关键词:
五水头孢唑林钠; 头孢唑林钠; 扁桃体周围炎; 炎症因子
Keywords:
Cefazolin sodium pentahydrate; Cefazolin sodium; Peritonsillitis; Inflammatory factors
分类号:
R766.18
DOI:
10.3969/j.issn.1006-1959.2023.09.021
文献标志码:
A
摘要:
目的 研究五水头孢唑林钠治疗扁桃体周围炎的临床疗效及对PCT、TNF-α及IL-6水平的影响。方法 选取2019年1月-2021年9月我院诊治的164例扁桃体周围炎患者为研究对象，采用随机数字表法分为观察组和对照组，各82例。对照组采用头孢唑林钠治疗，观察组采用五水头孢唑林钠治疗，比较两组临床疗效、炎症因子水平[降钙素原（PCT）、肿瘤坏死因子-α（TNF-α）、白细胞介素-6（IL-6）]、临床症状消失时间、不良反应发生率及治疗费用。结果 观察组治疗总有效率为95.12%，与对照组的93.90%比较，差异无统计学意义（P＞0.05）；两组治疗后PCT、TNF-α、IL-6水平均低于治疗前，且观察组低于对照组（P＜0.05）；观察组退热、咽痛、扁桃体肿大消失时间均短于对照组（P＜0.05）；观察组不良反应发生率为3.66%，低于对照组的12.20%（P＜0.05）；观察组治疗费用高于对照组（P＜0.05）。结论 五水头孢唑林钠治疗扁桃体周围炎的临床疗效满意，可缩短临床症状消失时间，改善炎症因子水平，降低不良反应发生率，但治疗成本较高，临床应结合患者具体情况科学合理选择。
Abstract:
Objective To study the clinical efficacy of cefazolin sodium pentahydrate in the treatment of peritonsillitis and its effect on PCT, TNF-α and IL-6 levels.Methods A total of 164 patients with peritonsillitis diagnosed and treated in our hospital from January 2019 to September 2021 were selected as the research objects. They were divided into observation group and control group by random number table method, with 82 cases in each group. The control group was treated with cefazolin sodium, and the observation group was treated with cefazolin sodium pentahydrate. The clinical efficacy, levels of inflammatory factors [procalcitonin (PCT), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6)], disappearance time of clinical symptoms, incidence of adverse reactions and treatment costs were compared between the two groups.Results The total effective rate of treatment in the observation group was 95.12%, which was compared with 93.90% in the control group, the difference was not statistically significant (P>0.05). After treatment, the levels of PCT, TNF-α and IL-6 in the two groups were lower than those before treatment, and those in the observation group were lower than those in the control group (P<0.05). The disappearance time of fever, sore throat and tonsil enlargement in the observation group was shorter than that in the control group (P<0.05). The incidence of adverse reactions in the observation group was 3.66%, which was lower than 12.20% in the control group (P<0.05). The treatment cost of the observation group was higher than that of the control group (P<0.05).Conclusion The clinical efficacy of cefazolin sodium pentahydrate in the treatment of peritonsillitis is satisfactory, which can shorten the disappearance time of clinical symptoms, improve the level of inflammatory factors and reduce the incidence of adverse reactions. However, the cost of treatment is high. Clinically, it should be scientifically and reasonably selected according to the specific conditions of patients.

参考文献/References:

[1]黎钢,丁勇,王山珊,等.头孢呋辛钠与疏风解毒胶囊对急性化脓性扁桃体炎患者的临床疗效评价[J].抗感染药学,2017,14(2):475-476.[2]刘丹,刘旭,姜燕.金叶败毒颗粒联合头孢呋辛钠治疗急性上呼吸道感染的临床研究[J].现代药物与临床,2018,33(11):2876-2879. [3]余爵波,程泽星,庄远岭,等.急性扁桃体炎引起扁桃体周围间隙感染的病原学特点与影响因素分析及预防[J].中国基层医药,2017,24(8):1173-1177.[4]徐娟,徐祖龙,张亚明,等.热毒宁注射液佐治儿童急性化脓性扁桃体炎的疗效[J].江苏医药,2017,43(23):1747-1748.[5]黄培练,潘艳东.疏风解毒胶囊联合头孢克洛干混悬剂治疗小儿扁桃体炎(风热证)临床观察[J].中国中医急症,2016,25(10):1984-1986. [6]姜衍,初阳,罗轶凡,等.五水头孢唑林钠稳定性研究[J].中国临床药理学杂志,2014,30(10):939-941,973.[7]李晋,郎罡,魏理,等.注射用五水头孢唑林钠不良反应前瞻性研究[J].中国药物警戒,2021,18(12):1171-1175.[8]卢正波,何兴川,魏毅,等.五水头孢唑林钠预防骨科术后切口感染效果及血清炎性因子变化分析[J].中华医院感染学杂志,2016,26(17):3987-3989. [9]王辉,李婧.注射用五水头孢唑林钠在妇产科感染治疗及术后感染预防中的安全性及有效性研究[J].河北医药,2017,39(6):875-877.[10]李洁,陈赫军,董维森,等.五水头孢唑林钠对比头孢唑林钠治疗细菌感染的成本-效果分析[J].中国药房,2017,28(29):4050-4053. [11]桂金艳,伍佳.银黄口服液联合头孢唑林钠治疗老年急性上呼吸道感染的临床研究[J].现代药物与临床,2019,34(6):1726-1730.[12]崇小萌,董欣,姚尚辰,等.头孢唑林钠与胶塞相容性关系的探讨[J].中国抗生素杂志,2019,44(8):942-945.[13]Chen LE,Shen YZ,Jiang DY,et al.Amoxicillin and clavulanate potassium in treating children with suppurative tonsillitis[J].J Biol Regul Homeost Agents,2017,31(3):625-629.[14]徐静,董高霞,肖建萍,等.预防性应用五水头孢唑林钠对会阴侧切术后切口愈合及阴道环境的影响[J].山西医药杂志,2017,25(10):31-33.[15]郑平.注射用五水头孢唑林钠治疗儿童轻、中度急性下呼吸道细菌性感染的疗效与安全性评价[J].医学综述,2018,12(2):160-162.[16]梁敦辉.五水头孢唑林钠对肛肠外科患者术后切口感染中的疗效及相关细胞因子的影响[J].吉林医学,2020,15(10):24-26.[17]朱赛楠,马序竹,初阳,等.五水头孢唑林钠群体药代动力学研究[J].中国临床药理学杂志,2017,28(1):291-293.[18]谷华.头孢唑林钠与头孢替安预防剖宫产术后感染的疗效比较[J].山西医药杂志,2019,24(1):101-103.[19]郭霞,陈炜,卢圆圆,等.7247例住院患者注射用五水头孢唑林钠用药情况分析[J].中华关节外科杂志,2017,12(1):149-151.

更新日期/Last Update: 1900-01-01